The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

This lengthy study with the drug Mounjaro seems to point to even better success than they’d hoped. Eli Lilly, the mind behind ...

Federal regulators shook up a rapidly growing pharmaceutical marketplace when they announced that tirzepatide, the active ingredient in Eli Lilly’s Mounjaro and Zepbound, was no longer in shortage ...

Lilly has earmarked $200 million for the upgrade, a company spokesperson confirmed to Fierce Pharma. The new project will ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...

Price distortions and dysfunction are nothing new in the $73 billion wedding industry. But the explosion of weight-loss drugs ...

All the state leaders should be getting their people out … to watch for ballot stuffing,” wrote the leader of the American ...

At a media event this evening, Tesla CEO Elon Musk showed off the company's new Cybercab and shared some details about ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...